IL-9 has both anti- and pro-tumor actions that are not well understood (65), and IL-9 has complicated anti-tumor and pro-tumor properties mediated by innate and adaptive immunity (66), including in PCa (67). This evidence concerns the gene IL9 and posterior cortical atrophy.